Compare STLN & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STLN | SWBI |
|---|---|---|
| Founded | N/A | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.8M | 637.4M |
| IPO Year | 2020 | 2000 |
| Metric | STLN | SWBI |
|---|---|---|
| Price | $6.93 | $13.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.2M | 599.4K |
| Earning Date | N/A | 06-17-2026 |
| Dividend Yield | N/A | ★ 3.37% |
| EPS Growth | 23.94 | ★ 36.67 |
| EPS | N/A | ★ 0.06 |
| Revenue | $502,729,000.00 | ★ $523,845,000.00 |
| Revenue This Year | N/A | $7.61 |
| Revenue Next Year | N/A | $3.72 |
| P/E Ratio | ★ N/A | $222.17 |
| Revenue Growth | ★ 27.79 | 10.36 |
| 52 Week Low | $5.76 | $8.14 |
| 52 Week High | $7.00 | $17.56 |
| Indicator | STLN | SWBI |
|---|---|---|
| Relative Strength Index (RSI) | 63.57 | 50.89 |
| Support Level | $5.93 | $12.09 |
| Resistance Level | N/A | $14.32 |
| Average True Range (ATR) | 0.38 | 0.51 |
| MACD | 0.08 | 0.11 |
| Stochastic Oscillator | 86.13 | 69.88 |
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
Smith & Wesson Brands Inc is a U.S.-based company engaged in manufacturing and selling firearms. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The company sells its products under the Smith and Wesson and Gemtech brands, which are used for defense, law enforcement, hunting, and sporting purposes. Geographically, it sells products globally, with maximum income being generated by the U.S. market from its handgun products.